source
- Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platformEli Lilly has been pushing at an open door by tacking on $870 million in biobucks to its existing collaboration with Gate Bioscience.
- FDA device center outlines FY 2027 guidance plan, targeting AI-enabled devices and change-control plansOn Oct 1, the FDA’s Center for Devices and Radiological Health announced its guidance agenda for fiscal year 2027. The top priority is finalizing guidance for artificial intelligence-enabled medic…